You appear to be offline. Some data may be unavailable until your connection is restored.

BDX

Stock

Becton Dickinson & Company

Create price alert
$215.71
+$1.19 (0.55%)
At close: Nov 12, 2026, 4:00 PM

Description

Becton, Dickinson & Company (BD) is a global medical‑technology firm that designs, manufactures and sells a wide range of medical supplies, devices, laboratory equipment and diagnostic systems for hospitals, clinics, research labs and the pharmaceutical industry. Its product portfolio includes needles and syringes, IV catheters, specimen‑collection tubes, infusion pumps, automated dispensing cabinets, flow‑cytometry instruments and molecular‑diagnostic platforms. BD operates in the broader health‑care equipment and diagnostics sector and is organized into three segments—Medical, Life Sciences and Interventional. The company holds leading market positions in several core categories such as hypodermic needles, prefilled drug‑delivery systems and clinical‑diagnostic technologies, supported by a global footprint and a history of strategic acquisitions.

Stay on top of BDX news

Subscribe to BDX for a personalized daily news feed and a morning digest delivered to your inbox, plus alerts when its coverage turns bullish or bearish.

Other Healthcare stocks in the S&P 500